IBAB Ion Beam Applications SA

Iba Press Release - HY 2020 RESULTS – AMENDMENT TO TIMING OF PUBLICATION

Iba Press Release - HY 2020 RESULTS – AMENDMENT TO TIMING OF PUBLICATION

HY 2020 Results – amendment to timing of publication

Louvain-La-Neuve, Belgium, 26 August 2020 - IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, IBA announces that, ahead of reporting its half year 2020 financial results today, there is an amendment to the timing of the publication. The Group will now publish its results today at 10am CEST. IBA shares will be suspended from trading until the publication of the announcement.

About IBA

IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,500 people worldwide, IBA has installed systems across the world.

IBA is listed on the pan-European stock exchange NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More information can be found at:

For further information, please contact:

IBA

Soumya Chandramouli

Chief Financial Officer



Thomas Ralet

Head of Corporate Communication



For media and investor enquiries:

Consilium Strategic Communications

Amber Fennell, Angela Gray, Lucy Featherstone, Lizzie Seeley

+44 (0) 20 3709 5700

Attachments

EN
26/08/2020

Underlying

IBABIon Beam Applications SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ion Beam Applications SA

 PRESS RELEASE
Free
IBAB Ion Beam Applic...

IBA – ACQUISITION OF OWN SHARES

IBA – ACQUISITION OF OWN SHARES Louvain-la-Neuve, Belgium, April 13th, 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026. Under this program, IBA has requested a financial intermediary to repurchase up to 400,000 IBA ordinary shares on its behalf under the terms of a mandate with validity until September 30th, 2026 (included), effective as from February 3rd, 2026...

April 13, 2026 1 EN
 PRESS RELEASE
Free
IBAB Ion Beam Applic...

IBA – ACQUISITION D’ACTIONS PROPRES

IBA – ACQUISITION D’ACTIONS PROPRES Louvain-la-Neuve, Belgique, 13 avril 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") communique par la présente certaines informations relatives à son programme de rachat d'actions annoncé le 2 février 2026. Dans le cadre de ce programme, IBA a demandé à un intermédiaire financier de racheter en son nom un maximum de 400.000 actions ordinaires IBA selon les termes d'un mandat valable jusqu'au 30 septembre 2026 et effectif à par...

April 13, 2026 1 EN
 PRESS RELEASE
Free
IBAB Ion Beam Applic...

Erratum: Correction of press release published on April 7th, 2026

Erratum: Correction of press release published on April 7th, 2026 The press release published on April 7th, related to the acquisition of own shares, contained the following errors: In the third paragraph, the number of repurchased shares shall read “32,000” instead of “16,000”;In the fifth paragraph, the number of total number of shares purchased under this program shall read “117,188” instead of “101,188”. As a result, the correct version shall read as follows: IBA – ACQUISITION OF OWN SHARES Louvain-la-Neuve, Belgium, April 9th, 2026 – 6 PM CET – In accordance with article 8:4 of t...

April 9, 2026 1 EN
 PRESS RELEASE
Free
IBAB Ion Beam Applic...

Erratum: Correction du communiqué de presse publié le 7 avril 2026

Erratum: Correction du communiqué de presse publié le 7 avril 2026 Le communiqué de presse publié le 7 avril 2026, relatif à l’acquisition d’actions propres, contenait les erreurs suivantes : Au troisième paragraphe, le nombre d’actions rachetées doit être “32.000 ” au lieu de “16.000” ;Dans le premier tableau, le nombre total d’actions rachetées figurant en ligne “Total ” doit être de “32.000 ” (au lieu de “16.000”) et le cours minimum figurant en ligne “Total ” doit être de “€12,58 ” (au lieu de “€12,64”) ;Au cinquième paragraphe, le nombre total d’actions acquises dans le cadre de ce ...

April 9, 2026 1 EN
 PRESS RELEASE
Free
IBAB Ion Beam Applic...

IBA – ACQUISITION OF OWN SHARES

IBA – ACQUISITION OF OWN SHARES Louvain-la-Neuve, Belgium, April 7th, 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026. Under this program, IBA has requested a financial intermediary to repurchase up to 400,000 IBA ordinary shares on its behalf under the terms of a mandate with validity until September 30th, 2026 (included), effective as from February 3rd, 2026,...

April 7, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch